Phase 2 Extensive Stage Lung Small Cell Cancer Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
Extensive Stage Lung Small Cell Cancer
PrECOG, LLC.60 enrolled5 locationsNCT07057791
Recruiting
Phase 2
A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2
Extensive Stage Lung Small Cell Cancer
ETOP IBCSG Partners Foundation48 enrolled19 locationsNCT07203053
Recruiting
Phase 2
Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC
Extensive Stage Lung Small Cell Cancer
Zhejiang Cancer Hospital100 enrolled1 locationNCT06350162